Cochlear implantation outcomes in patients with autoimmune and immune-mediated inner ear disease

Otology and Neurotology

Volumn 31, Issue 8, 2010, Pages 1337-1342

  Aftab, Saba ^a   Semaan, Maroun T ^a   Murray, Gail S ^a   Megerian, Cliff A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Autoimmune innerear disease; Cochlear implantation; Cochlear ossification

Indexed keywords

ADULT; AGED; ARTICLE; AUDITORY THRESHOLD; AUTOIMMUNE DISEASE; COCHLEA PROSTHESIS; FEMALE; HEARING IMPAIRMENT; HUMAN; IMMUNOLOGY; IMPLANTATION; INNER EAR DISEASE; MALE; METHODOLOGY; MIDDLE AGED; PURE TONE AUDIOMETRY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; AUTOIMMUNE DISEASES; COCHLEAR IMPLANTATION; COCHLEAR IMPLANTS; DEAFNESS; FEMALE; HUMANS; LABYRINTH DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77958084063     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3181f0c699     Document Type: Conference Paper

References (18)

1. McCabe B. Autoimmune sensorineural hearing loss. Ann Otol Rhinol 1979;88:585-9.
2. Harris JP, Weisman MH, Derebery JM, et al. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 2003;290:1875-83.
3. Cohen S, Shoup A, Weisman MH, et al. Etanercept treatment for autoimmune inner disease: results of a pilot placebo-controlled study. Otol Neurotol 2005;26:903-7.
4. Ma C, Billings P, Harris JP, et al. Characterization of an experimentally induced inner ear immune response. Laryngoscope 2000; 110:451-6.
5. Keithley EM, Chen MC, Linthicum F. Clinical diagnoses associated with histologic findings of fibrotic tissue and new bone in the inner ear. Laryngoscope 1998;108:87-91.
6. Swartz JD, Mandell DM, Faerber EN, et al. Labyrinthine ossification: etiologies and CT findings. Radiology 1985;157:395-8.
7. Suga F, Lindsay JR. Labyrinthitis ossificans. Ann Otol Rhinol Laryngol 1977;86:17-29.
8. Zorowka P, Jennerjahn B, Kraft E. Labyrinthitis ossificans after pneumococcal meningitis [in German]. HNO 1991;39:37-40.
9. Benson AG. Labyrinthitis ossificans secondary to autoimmune inner ear disease a previously unreported condition. Otolaryngol Head Neck Surg 2010;142:772-3.
10. Kemink JL, Zimmerman-Phillips S, Kileny PR, et al. Auditory performance of children with cochlear ossification and partial implant insertion. Laryngoscope 1992;102:1001-5.
11. Nadol JB Jr, Hsu WC. Histopathologic correlation of spiral ganglion cell count and new bone formation in the cochlea following meningogenic labyrinthitis and deafness. Ann Otol Rhinol Laryngol 1991;100:712-6.
12. Hinojosa R, Green JD Jr, Marion MS. Ganglion cell populations in labyrinthitis ossificans. Am J Otol 1991:3-7; discussion 18-21.
13. Rauch SD, Herrmann BS, Davis LA, et al. Nucleus 22 cochlear implantation results in postmeningitic deafness. Laryngoscope 1997; 107:1606-9.
14. Eshraghi AA, Telischi FF, Hodges AV, et al. Changes in programming over time in postmeningitis cochlear implant users. Otolaryngol Head Neck Surg 2004;131:885-9.
15. Quaranta N, Bartoli R, Giagnotti F, et al. Cochlear implants in systemic autoimmune vasculitis syndromes. Acta Otolaryngol Suppl 2002;548:44-8.
16. Pasanisi E, Vincenti V, Bacciu A, et al. Cochlear implantation and Cogan syndrome. Otol Neurotol 2003;24:601-4.
17. Geier L, Gilden J, Luetje CM, et al. Delayed perception of cochlear implant stimulation in children with postmeningitic ossified cochleae. Am J Otol 1993;14:556-61.
18. Roland JT Jr, Coelho DH, Pantelides H, et al. Partial and doublearray implantation of the ossified cochlea. Otol Neurotol 2008;29: 1068-75.